Mammography devices market seen reaching $3.81 billion by 2030

The mammography devices market is projected to grow from $2.2 billion in 2025 to $3.81 billion by 2030, driven by breast cancer screening demand, digital imaging upgrades and wider use of AI tools. North America led the market in 2025, while Asia-Pacific is expected to grow fastest through 2030.

Why it matters: - The mammography devices market is tied to early breast cancer detection, which can improve diagnosis, treatment planning and patient outcomes. - Rising breast cancer incidence is increasing demand for screening equipment and related imaging systems. - The shift from analog systems to digital and AI-enabled imaging is reshaping how providers screen for breast cancer.

What happened: - The Business Research Company projected the mammography devices market will rise from $2.2 billion in 2025 to $2.46 billion in 2026. - The same forecast puts the market at $3.81 billion by 2030. - The report was released Aug. 14, 2026, from London. - A free sample report and the full market report were made available.

The details: - The market grew on continued use of analog mammography devices, limited breast imaging access in rural areas, higher breast cancer awareness, adoption of screen-film mammography and expansion of specialty clinics and diagnostic centers. - The market is forecast to expand at an 11.5% CAGR from 2026 through 2030. - Full-field digital mammography, 3D digital mammography and digital breast tomosynthesis are expected to drive the next phase of growth. - Computer-aided detection and AI-driven imaging analysis are becoming more integrated into mammography systems. - Portable mammography systems are seeing wider deployment. - Government-led breast cancer screening initiatives are supporting demand. - The report identified stronger adoption of digital systems, growth in tomosynthesis, expanded use of portable units, CAD advances and early screening programs as key trends. - Mammography devices produce detailed breast tissue images for screening and diagnostic use. - The devices help healthcare providers identify abnormalities early. - In January 2024, the American Cancer Society estimated about 310,720 new invasive breast cancer cases among women in the U.S. and about 42,250 deaths in the same year. - The American Cancer Society said breast cancer incidence is rising 0.6% annually, including a 1.0% annual increase among women under 50. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region over the forecast period. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

Between the lines: - The forecast suggests mammography is moving from a hardware replacement cycle into a broader technology upgrade cycle. - Digital imaging, tomosynthesis and AI are becoming central to competitive differentiation in breast screening. - The regional outlook points to mature demand in North America and faster adoption potential in emerging markets. - The rise in breast cancer cases is creating a durable demand base for both screening and diagnostic systems.

What's next: - Market growth will likely depend on how quickly health systems adopt digital mammography, tomosynthesis and AI-enabled workflows. - Portable systems may expand access in underserved regions and outpatient settings. - Government screening programs could continue to shape procurement and deployment decisions. - The Business Research Company said its 2026 reports include market attractiveness scoring, TAM analysis, company scoring matrix graphics, Excel-based forecasting dashboards, market hotspots infographics and updated technology and trend analysis. - Contact details provided in the release point readers to Saumya Sahay and The Business Research Company for more information.

The bottom line: - Mammography devices are on a steady growth path through 2030, with digital imaging and breast cancer screening demand doing most of the heavy lifting.